Merck Will Drop Up To $375M On Cancer Treatment Co.
New Jersey-based Merck & Co. Inc. has scooped a research company developing a drug to treat blood-based cancers for a potential sale price of $375 million, according to a statement released...To view the full article, register now.
Already a subscriber? Click here to view full article